Document Detail


The development of bone mineral density and the occurrence of osteoporosis from 15 to 20 years of disease onset in patients with rheumatoid arthritis.
MedLine Citation:
PMID:  15895889     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To ascertain the occurrence of osteoporosis and the development of central bone mineral density (BMD) in long-term rheumatoid arthritis (RA) METHODS: BMD of the lumbar spine (L2-L4) and the femoral neck were measured by dual-energy X-ray absorptiometry in a cohort of 59 patients (49 women and 10 men) with rheumatoid factor-positive RA followed up for 20 years. BMD measurements were obtained at the 15- and 20-year follow-up visits. RESULTS: At the 15-year check-up the mean age was 61 (SD 13)for men and 54 (SD 11) years for women. Bone densitometry of these patients revealed decreased BMD at both lumbar spine and femoral neck, the mean T-scores being -1.1 [95%CI: -1.6 to -0.6] and -1.3 [95%CI: -1.6 to -1], respectively). Eighteen (31 %) patients thus had osteoporosis (BMD T -score < or = -2.5) and 32 (54%) patients were osteopenic (BMD T-score -1.0 to -2.5). However, when compared with reference values, the decreases in central bone mineral in this patient group were of low degree; the mean Z-score -0.2 [95%CI: -0.7 to 0.2] at the lumbar spine and -0.5 [95%CI: -0.8 to -0.3] at the femoral neck, respectively. After the subsequent five years the mean Z-score increased 0.45 [95%CI: 0.32 to 0.58] at the lumbar spine and the mean T-score decreased -0.20 [95%CI: -0.32 to -0.08] at the femoral neck. ESR, Larsen score, gender and cumulative dose of prednisolone during the 5 year follow-up and HAQ-index were used as explanatory parameters of BMD change between the 15- and 20-year follow-ups. None of these parameters explained the BMD change. CONCLUSION: We conclude that in long-term RA central bone densities seemed to be only moderately decreased after 15 years from eruption of RA. No essential change in central BMD was found after the consecutive 5 years.
Authors:
H Hämäläinen; H Kautiainen; K Kaarela; A Kotaniemi
Related Documents :
16051419 - Effects of chronic liver disease on bone mineral density and bone metabolism markers in...
8704349 - Screening for osteopenia and osteoporosis: selection by body composition.
18622949 - Habitual tea drinking and bone mineral density in postmenopausal turkish women: investi...
12148389 - Effect of combined oral contraceptives on bone mineral density in pre and postmenopausa...
17463099 - Identification of post-menopausal women at risk of osteoporosis by trained general dent...
11527049 - Bone mineral density of the spine, hip and distal forearm in representative samples of ...
9668929 - Stages of acquisition and cessation for adolescent smoking: an empirical integration.
12342699 - Covariates of divorce in australia: an analysis using proportional hazard models.
16905719 - Marital status and longevity in the united states population.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Clinical and experimental rheumatology     Volume:  23     ISSN:  0392-856X     ISO Abbreviation:  Clin. Exp. Rheumatol.     Publication Date:    2005 Mar-Apr
Date Detail:
Created Date:  2005-05-17     Completed Date:  2005-07-26     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8308521     Medline TA:  Clin Exp Rheumatol     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  193-8     Citation Subset:  IM    
Affiliation:
The Rheumatism Foundation Hospital, Heinola, Finland. harri.hamalainen@reuma.fi
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Absorptiometry, Photon
Arthritis, Rheumatoid / complications,  drug therapy,  metabolism*,  pathology
Bone Density*
Bone Diseases, Metabolic / complications,  metabolism*,  pathology
Female
Femur Neck / metabolism,  radiography
Health Status
Humans
Lumbar Vertebrae / metabolism,  radiography
Male
Middle Aged
Osteoporosis / complications,  metabolism*,  pathology
Prednisolone / therapeutic use
Reference Values
Severity of Illness Index
Chemical
Reg. No./Substance:
50-24-8/Prednisolone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Inflammatory cell infiltrate and RANKL/OPG expression in rheumatoid synovium: comparison with other ...
Next Document:  Prevalence of antiphospholipid antibodies in systemic sclerosis and association with primitive pulmo...